PMC:7029759 / 21105-21210
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
471 | 82-86 | Gene | denotes | ACE2 | Gene:59272 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T345 | 82-86 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T344 | 87-95 | GO:0042571 | denotes | antibody |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T122 | 87-95 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T181 | 10-11 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T135 | 0-105 | Sentence | denotes | There are a couple of design considerations when thinking about how to employ the ACE2 antibody strategy. |